GE

Genexine, Inc.

Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.

095700 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙로 172 바이오이노베이션파크, 강서구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Genexine, Inc. is a clinical-stage biopharmaceutical company focused on the research and development of innovative immunotherapeutics and next-generation biologics. The company leverages its proprietary hyFc® platform technology to create long-acting treatments. Its primary focus areas are immuno-oncology and rare diseases. Key pipeline assets include GX-I7, a long-acting interleukin-7 designed to amplify T-cell counts for cancer therapy, as well as late-stage candidates GX-E4 for anemia and GX-H9 for growth hormone deficiency. Genexine aims to develop novel and "bio-better" drugs to address serious health issues and improve patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-20 00:00
Regulatory News Service
투자판단관련주요경영사항 (GXI7 관련 마일스톤 기술료 청구)
Korean 7.1 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 29.4 KB
2025-03-26 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 16.5 KB
2025-03-26 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 13.9 KB
2025-03-26 00:00
Board/Management Information
대표이사변경
Korean 10.5 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 18.0 KB
2025-03-10 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 17.2 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 152.9 KB
2025-03-10 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 133.5 KB
2025-03-10 00:00
Audit Report / Information
감사보고서제출
Korean 19.5 KB
2025-03-10 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 618.9 KB
2025-02-26 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과) (재발성 교모세포종 환자에서 베바시주맙 (bevacizumab)과 GX-I7 병용…
Korean 14.1 KB
2025-02-06 00:00
Regulatory News Service
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.5 KB

Automate Your Workflow. Get a real-time feed of all Genexine, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Genexine, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.